Philip DiSaia resigned as president of the GOG Foundation Inc. and as one of the three group chairs of NRG Oncology.
Edith Peterson Mitchell, researcher, medical oncologist, and retired brigadier general was chosen as the 2017 American Society for Radiation Oncology Honorary Member. Mtchell will receive the award on Sept. 26 at ASTRO's 59th Annual Meeting in San Diego. “Dr. Edith Mitchell has been a longtime proponent of combined modality treatment—using chemotherapy and radiation therapy together in order to provide cancer patients with the best possible outcomes,” says ASTRO chair David Beyer. “Our specialty is privileged to have a champion such as Dr. Mitchell, who is a widely respected clinician as well as decorated military veteran. Her service to both our country and our field is laudable.”
Though NCI-MATCH and Pediatric MATCH are similar in structure, they represent different approaches to oncology.
NCI and the Children's Oncology Group opened enrollment in Pediatric Molecular Analysis for Therapy Choice—Pediatric MATCH—a long-awaited precision medicine trial.
AstraZeneca and Merck & Co. Inc. entered a global collaboration to co-develop and co-commercialize AstraZeneca's Lynparza (olaparib) for multiple cancer types.
Novartis said the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending approval of Rydapt (midostaurin) for the treatment of adults with newly diagnosed acute myeloid leukemia who are FLT3 mutation-positive.
A report from the American Cancer Society Cancer Action Network and Georgetown University Center on Health Insurance Reforms shows that while opportunities for coverage have improved, cancer patients struggle with financial challenges in affording their treatment, despite reductions in out-of-pocket costs and patient protections under current law.
Leading national cancer organizations released a joint position statement to guide the future of cancer health disparities research.
Andrew Baschnagel was awarded the 2017 UW Carbone Cancer Center Young Investigator Award.
“If you want to see what a cure looks like, you already have,” said Tom Whitehead as his daughter Emily joined him at the lectern at the public hearing of the FDA Oncologic Drugs Advisory Committee July 12.“She's standing right beside me.”
